Literature DB >> 12073108

Total hip replacement in sickle cell disease.

F Al-Mousawi1, A Malki, A Al-Aradi, M Al-Bagali, A Al-Sadadi, M M Y Booz.   

Abstract

We report on 35 total hip replacement arthroplasties in 28 patients with avascular necrosis of the femoral head secondary to sickle cell disease (SCD). There were 15 men and 13 women with a mean age of 27.5 years. In all patients Harris hip scores improved from a mean of 36 pre-operative to 86 post-operative. However, at a mean follow-up of 9.5 (5-15) years six hips failed due to symptomatic aseptic loosening and one due to late deep infection. Our results support the decision to offer the procedure for patients with arthritic hips secondary to SCD. It is important that patients and surgeons should be aware of the wide varieties of complications.

Entities:  

Mesh:

Year:  2002        PMID: 12073108      PMCID: PMC3620878          DOI: 10.1007/s00264-002-0337-5

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  19 in total

1.  Hip resurfacing in patients who have osteonecrosis and are 25 years or under.

Authors:  Siraj A Sayeed; Aaron J Johnson; D Alex Stroh; Thomas P Gross; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

Review 2.  Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review.

Authors:  Henning R Johannson; Michael G Zywiel; David R Marker; Lynne C Jones; Mike S McGrath; Michael A Mont
Journal:  Int Orthop       Date:  2010-02-25       Impact factor: 3.075

Review 3.  Bilateral pulmonary embolism in an adolescent with sickle cell disease and a recent total hip arthroplasty: a case report and review of the literature.

Authors:  Jeremy M Burnham; Marlene Broussard; Todd Milbrandt
Journal:  Iowa Orthop J       Date:  2014

4.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

5.  Total THA in adult osteonecrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Sebastien Zilber; Paolo Filippini; Gilles Mathieu; Alexandre Poignard; Frederic Galacteros
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

6.  Alumina-on-alumina hip arthroplasty in patients younger than 30 years old.

Authors:  R Nizard; D Pourreyron; A Raould; D Hannouche; L Sedel
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

Review 7.  Surgical management of osteonecrosis of the femoral head in patients with sickle cell disease.

Authors:  Atul F Kamath; Michael H McGraw; Craig L Israelite
Journal:  World J Orthop       Date:  2015-11-18

8.  Massive septic pelvic osteolysis following revision total hip arthroplasty in a patient with sickle cell anemia: clinical presentation and review of the literature.

Authors:  Panagiotis Korovessis; Thomas Repantis
Journal:  Eur J Orthop Surg Traumatol       Date:  2011-09-27

9.  Revision total hip arthroplasty in the United States: national trends and in-hospital outcomes.

Authors:  Brian E Schwartz; Hristo I Piponov; Cory W Helder; William F Mayers; Mark H Gonzalez
Journal:  Int Orthop       Date:  2016-02-01       Impact factor: 3.075

10.  Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample.

Authors:  Aaron J Johnson; Michael A Mont; Audrey K Tsao; Lynne C Jones
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.